While the expression of Fpr1 and Fpr2 in the hypothalamus is lower compared to other tissues (data not shown), it will be necessary to investigate the potential pathway of obesity reduction through inhibiting the inflammatory response in the hypothalamus, as WKYMVm demonstrates anti‐inflammatory characteristics. The gene discussed is FPR1; the disease is obesity due to melanocortin 4 receptor deficiency.